Physician
Universal Community Health Center
Universal Community Health Center was paid $20.45M by Medicaid between Jan 2018 and Dec 2024, across 152 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 92% of everything it billed.
33Billing provider infoUNIVERSAL COMMUNITY HEALTH CENTER
LOS ANGELES, CA 90021
LOS ANGELES, CA 90021
33aNPI1093023277assigned 09/21/2010
33bProvider typeFamily Medicine Physician
28Total paid$20.45M
24GClaims695,202
24DCodes billed152
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in California
Rank by total paid#23 of 2,511
Median peer was paid$13K
This provider vs. median1,592×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,864 | $990K | |
| 2019 | 41,784 | $998K | |
| 2020 | 59,826 | $1.96M | |
| 2021 | 111,220 | $2.96M | |
| 2022 | 111,694 | $2.44M | |
| 2023 | 177,441 | $5.03M | |
| 2024incomplete | 167,373 | $6.08M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 92% | 131,150 | 99,960 | $18.72M |
| 00003 | Internal/system code - not a standard HCPCS code | 3.2% | 2,640 | 2,442 | $654K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.4% | 125,570 | 68,913 | $290K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 1.0% | 8,851 | 4,176 | $215K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 55,317 | 31,345 | $94K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 9,262 | 6,016 | $80K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 7,665 | 6,624 | $46K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 4,119 | 2,851 | $43K |
| 0001A | <1% | 1,216 | 697 | $40K | |
| 0002A | <1% | 1,172 | 674 | $37K | |
| 0012A | <1% | 510 | 310 | $19K | |
| 90756 | <1% | 958 | 887 | $16K |
140 more codes
| 0011A | <1% | 525 | $14K | |
| 0004A | <1% | 455 | $11K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 3,253 | $11K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 3,435 | $10K |
| 90674 | <1% | 968 | $10K | |
| 90686 | <1% | 3,531 | $9K | |
| 0071A | <1% | 522 | $8K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 2,835 | $8K |
| 96127 | <1% | 62,666 | $8K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 3,415 | $7K |
| 90715 | <1% | 985 | $6K | |
| 0072A | <1% | 364 | $6K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 4,310 | $6K |
| G9920 | Screening performed and negative | <1% | 4,174 | $6K |
| 0064A | <1% | 235 | $5K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 10,129 | $5K |
| G0467 | Community health center visit, returning patient | <1% | 240 | $4K |
| 0124A | <1% | 243 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 919 | $4K |
| H0049 | Alcohol and/or drug screening | <1% | 374 | $4K |
| 92551 | <1% | 6,640 | $4K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 2,452 | $3K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 767 | $3K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,437 | $3K |
| 81025 | <1% | 3,758 | $3K | |
| 90651 | <1% | 974 | $3K | |
| 99173 | <1% | 6,644 | $2K | |
| 90670 | <1% | 985 | $2K | |
| 0031A | <1% | 91 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 470 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 263 | $2K |
| 90734 | <1% | 524 | $2K | |
| 96156 | <1% | 773 | $1K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 245 | $1K |
| 3008F | <1% | 76,269 | $1K | |
| J3490 | Unclassified drugs | <1% | 38 | $1K |
| 3078F | <1% | 29,313 | $1K | |
| 90656 | <1% | 286 | $1K | |
| 99385 | <1% | 160 | $1K | |
| 82962 | <1% | 7,350 | $1K | |
| 3074F | <1% | 32,113 | $927.34 | |
| 99201 | <1% | 910 | $868.33 | |
| 90633 | <1% | 442 | $841.48 | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 68 | $623.77 |
| 80061 | Lipid panel | <1% | 3,851 | $620.19 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 25 | $603.90 |
| 86318 | <1% | 2,145 | $595.76 | |
| 90677 | <1% | 151 | $558.00 | |
| 90647 | <1% | 429 | $513.18 | |
| 90620 | <1% | 100 | $491.76 | |
| 97803 | <1% | 668 | $460.49 | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 54 | $457.03 |
| T1016 | Case management, each 15 minutes | <1% | 326 | $377.46 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 424 | $349.19 |
| 69210 | <1% | 358 | $319.41 | |
| 81002 | <1% | 2,771 | $298.62 | |
| 90723 | <1% | 401 | $296.91 | |
| 99401 | <1% | 408 | $216.98 | |
| 99000 | <1% | 1,493 | $212.02 | |
| 90710 | <1% | 146 | $198.00 | |
| 92552 | <1% | 154 | $134.67 | |
| 90661 | <1% | 540 | $114.37 | |
| 92250 | <1% | 36 | $112.84 | |
| 90688 | <1% | 102 | $112.30 | |
| 3725F | <1% | 12,812 | $98.68 | |
| 99383 | <1% | 44 | $93.58 | |
| 90681 | <1% | 65 | $81.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 64 | $67.01 |
| 90697 | <1% | 60 | $63.00 | |
| 99384 | <1% | 18 | $54.59 | |
| 90707 | <1% | 58 | $54.00 | |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 399 | $53.75 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 83 | $47.86 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 57 | $44.80 |
| 3077F | <1% | 3,367 | $43.65 | |
| 90696 | <1% | 46 | $36.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 695 | $33.27 |
| 0502F | <1% | 4,591 | $28.83 | |
| 1111F | <1% | 1,615 | $28.68 | |
| 1160F | <1% | 2,004 | $28.63 | |
| 82274 | <1% | 173 | $28.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 217 | $27.68 |
| 91300 | <1% | 1,525 | $27.00 | |
| 3079F | <1% | 10,280 | $24.08 | |
| 3075F | <1% | 5,865 | $24.05 | |
| 85018 | <1% | 359 | $16.17 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 177 | $8.08 |
| 91307 | <1% | 707 | $4.81 | |
| 1159F | <1% | 1,992 | $0.11 | |
| 2022F | <1% | 72 | $0.05 | |
| 3080F | <1% | 1,041 | $0.04 | |
| 1158F | <1% | 947 | $0.01 | |
| 2028F | <1% | 566 | $0.01 | |
| 90716 | <1% | 58 | $0.01 | |
| Z6304 | 0% | 1,048 | $0.00 | |
| NOBLL | 0% | 86 | $0.00 | |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 0% | 37 | $0.00 |
| 86703 | 0% | 51 | $0.00 | |
| 99397 | 0% | 67 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 54 | $0.00 |
| Z6500 | 0% | 42 | $0.00 | |
| 99177 | 0% | 12 | $0.00 | |
| 1090F | 0% | 67 | $0.00 | |
| 99497 | 0% | 54 | $0.00 | |
| 3288F | 0% | 55 | $0.00 | |
| 1003F | 0% | 55 | $0.00 | |
| 4004F | 0% | 14 | $0.00 | |
| 86328 | 0% | 52 | $0.00 | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 0% | 32 | $0.00 |
| G0468 | Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv | 0% | 27 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 32 | $0.00 |
| 90685 | 0% | 39 | $0.00 | |
| 0121A | 0% | 13 | $0.00 | |
| 01 | Inj., retisert, 0.01 mg | 0% | 80 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 77 | $0.00 |
| 92060 | 0% | 159 | $0.00 | |
| Z6204 | 0% | 1,033 | $0.00 | |
| Z6404 | 0% | 1,030 | $0.00 | |
| 91306 | 0% | 158 | $0.00 | |
| 90839 | 0% | 207 | $0.00 | |
| 91301 | 0% | 464 | $0.00 | |
| 86580 | 0% | 26 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 14 | $0.00 |
| 3044F | 0% | 21 | $0.00 | |
| 1170F | 0% | 55 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 13 | $0.00 |
| 91303 | 0% | 57 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 89 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 62 | $0.00 |
| 93000 | 0% | 30 | $0.00 | |
| 87340 | 0% | 34 | $0.00 | |
| 99386 | 0% | 45 | $0.00 | |
| 1126F | 0% | 26 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 38 | $0.00 |
| 4086F | 0% | 12 | $0.00 | |
| 1034F | 0% | 14 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 32 | $0.00 |
| Z1032 | 0% | 24 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 25 | $0.00 |
| 3061F | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAVEZ, EDGAR (CEO)
| Provider | Location | Paid |
|---|---|---|
| Universal Community Health Center | Los Angeles, CA | $6.73M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.